We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

162 hedge funds and large institutions have $1.23B invested in Aerie Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,450% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 4

300% more funds holding in top 10

Funds holding in top 10: 2 → 8 (+6)

151% more capital invested

Capital invested by funds: $489M → $1.23B (+$737M)

56% more funds holding

Funds holding: 104 → 162 (+58)

40% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 35

29% more call options, than puts

Call options by funds: $34.6M | Put options by funds: $26.8M

Holders
162
Holders Change
+58
Holders Change %
+55.77%
% of All Funds
4.32%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.21%
New
62
Increased
49
Reduced
35
Closed
4
Calls
$34.6M
Puts
$26.8M
Net Calls
+$7.76M
Net Calls Change
+$3.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17.6M
2
FCMI
Foresite Capital Management II
California
+$15.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$12.3M
4
ACA
Avoro Capital Advisors
New York
+$11M
5
Ameriprise
Ameriprise
Minnesota
+$9.67M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$26.1M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.91M
3
PHS
PFM Health Sciences
California
-$8.27M
4
NC
Northpointe Capital
Michigan
-$4.54M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$4.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFS
151
MSI Financial Services
Massachusetts
$19K – – –
IA
152
IFP Advisors
Florida
$15K – – –
MA
153
MUFG Americas
New York
$14K – – –
Bank of Montreal
154
Bank of Montreal
Ontario, Canada
$14K +$8.07K +366 New
JFA
155
JNBA Financial Advisors
Minnesota
$10K +$5.69K +258 New
S
156
SignatureFD
Georgia
$10K +$5.69K +258 New
ACH
157
ArrowMark Colorado Holdings
Colorado
$10K +$6.13K +278 New
KF
158
Krilogy Financial
Missouri
$8K +$4.41K +200 New
MCM
159
Manchester Capital Management
Vermont
$6K – – –
TCIM
160
TIAA CREF Investment Management
New York
$4.27K +$237K +10,759 +11%
SEI Investments
161
SEI Investments
Pennsylvania
$1K -$22 -1 -3%
VOYA Investment Management
162
VOYA Investment Management
Georgia
$401 – – –
KCM
163
Kennedy Capital Management
Missouri
– -$946K -53,742 Closed
GCP
164
GSA Capital Partners
United Kingdom
– -$219K -12,437 Closed
Teacher Retirement System of Texas
165
Teacher Retirement System of Texas
Texas
– -$58K -3,297 Closed
JP Morgan Chase
166
JP Morgan Chase
New York
– -$5K -284 Closed
3 4 5 6
7

AERI Hedge Fund Activity: Q3 2016 in Review

162 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2016, worth a combined $1.23B — up 151% from $489M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new AERI positions and 4 closed out — a net gain of 58 holders — while 49 added to existing stakes and 35 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $17.6M. The largest seller was Deerfield Management, cutting an estimated $26.1M.

  • 162 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $1.23B of Aerie Pharmaceuticals stock for Q3 2016, up 151% quarter-over-quarter.
  • 62 funds opened new Aerie Pharmaceuticals positions in Q3 2016 and 4 closed out, a net change of +58 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2016 was OrbiMed, an estimated $17.6M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2016 was Deerfield Management, an estimated $26.1M sold.

Based on aggregated 13F filings for Q3 2016.